New definition for the partial remission period in children and adolescents with type 1 diabetes
about
Correlation Among Hypoglycemia, Glycemic Variability, and C-Peptide Preservation After Alefacept Therapy in Patients with Type 1 Diabetes Mellitus: Analysis of Data from the Immune Tolerance Network T1DAL Trial.Data on correlations between T cell subset frequencies and length of partial remission in type 1 diabetes.A predictive model for lack of partial clinical remission in new-onset pediatric type 1 diabetes.A20 Inhibits β-Cell Apoptosis by Multiple Mechanisms and Predicts Residual β-Cell Function in Type 1 Diabetes.Disease progression and search for monogenic diabetes among children with new onset type 1 diabetes negative for ICA, GAD- and IA-2 Antibodies.The PTPN22 C1858T gene variant is associated with proinsulin in new-onset type 1 diabetes.CTSH regulates β-cell function and disease progression in newly diagnosed type 1 diabetes patients.Polymorphism of the FTO Gene Influences Body Weight in Children with Type 1 Diabetes without Severe Obesity.Characteristics and determinants of partial remission in children with type 1 diabetes using the insulin-dose-adjusted A1C definitionGene CNVs and protein levels of complement C4A and C4B as novel biomarkers for partial disease remissions in new-onset type 1 diabetes patientsNeurological consequences of diabetic ketoacidosis at initial presentation of type 1 diabetes in a prospective cohort study of children.Complex multi-block analysis identifies new immunologic and genetic disease progression patterns associated with the residual β-cell function 1 year after diagnosis of type 1 diabetes.Combination therapy with sitagliptin and lansoprazole in patients with recent-onset type 1 diabetes (REPAIR-T1D): 12-month results of a multicentre, randomised, placebo-controlled, phase 2 trial.Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same?Uncoupling of proliferation and cytokines from suppression within the CD4+CD25+Foxp3+ T-cell compartment in the 1st year of human type 1 diabetes.CGM-measured glucose values have a strong correlation with C-peptide, HbA1c and IDAAC, but do poorly in predicting C-peptide levels in the two years following onset of diabetes.Peripheral blood monocyte gene expression profile clinically stratifies patients with recent-onset type 1 diabetes.Comparison of Metabolic Outcomes in Children Diagnosed with Type 1 Diabetes Through Research Screening (Diabetes Autoimmunity Study in the Young [DAISY]) Versus in the Community.Antibody Response to Serpin B13 Induces Adaptive Changes in Mouse Pancreatic Islets and Slows Down the Decline in the Residual Beta Cell Function in Children with Recent Onset of Type 1 Diabetes Mellitus.Genetic Risk Score Modelling for Disease Progression in New-Onset Type 1 Diabetes Patients: Increased Genetic Load of Islet-Expressed and Cytokine-Regulated Candidate Genes Predicts Poorer Glycemic ControlProinsulin and heat shock protein 90 as biomarkers of beta-cell stress in the early period after onset of type 1 diabetes.A pilot study showing associations between frequency of CD4(+) memory cell subsets at diagnosis and duration of partial remission in type 1 diabetes.Potential beneficial effects of a gluten-free diet in newly diagnosed children with type 1 diabetes: a pilot studyPediatric diabetes consortium T1D New Onset (NeOn) study: clinical outcomes during the first year following diagnosis.Four-year clinical remission of type 1 diabetes mellitus in two patients treated with sitagliptin and vitamin D3Immunologic and metabolic biomarkers of β-cell destruction in the diagnosis of type 1 diabetes.Lessons from the Hvidoere International Study Group on childhood diabetes: be dogmatic about outcome and flexible in approach.Role of the C1858T polymorphism of protein tyrosine phosphatase non-receptor type 22 (PTPN22) in children and adolescents with type 1 diabetes.Immune-Modulating Therapy for Rheumatologic Disease: Implications for Patients with Diabetes.Clinical outcomes in youth beyond the first year of type 1 diabetes: Results of the Pediatric Diabetes Consortium (PDC) type 1 diabetes new onset (NeOn) study.HbA1c tracking and bio-psychosocial determinants of glycaemic control in children and adolescents with type 1 diabetes: retrospective cohort study and multilevel analysis.Diabetic ketoacidosis at the onset of type 1 diabetes is associated with future HbA1c levels.Effect of autoimmunity risk loci on the honeymoon phase in type 1 diabetes.Stimulated urine C-peptide creatinine ratio vs serum C-peptide level for monitoring of β-cell function in the first year after diagnosis of Type 1 diabetes.Fall in C-Peptide During First 4 Years From Diagnosis of Type 1 Diabetes: Variable Relation to Age, HbA1c, and Insulin Dose.Factors contributing to partial remission in type 1 diabetes: analysis based on the insulin dose-adjusted HbA1c in 3657 children and adolescents from Germany and Austria.Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes.Remission without insulin therapy on gluten-free diet in a 6-year old boy with type 1 diabetes mellitusOne year remission of type 1 diabetes mellitus in a patient treated with sitagliptin.Insulin-dose-adjusted HbA1c-defined partial remission phase in a paediatric population--when is the honeymoon over?
P2860
Q31099230-FF7E4B3B-C577-44F3-956C-6522E39B2622Q31125792-F9678FB1-29AD-442E-B8A2-A4063C2BEAE7Q33620874-4BB2E461-3386-40C3-8BB3-A6D357A663EBQ33631445-C6AD0344-3C26-45A4-BEAC-FB7403D177EAQ33700991-AD4A44EC-70CE-4505-97E1-9BC6FE5E844FQ33853306-9F4165A1-2FB2-4501-95A7-139C58212B10Q33925780-A5FD8968-1069-41DB-B1DF-798CD04F1AB7Q34145940-1B0B6EFA-605A-41AF-BBD7-70089459CA11Q34181376-084D1B5F-E8E2-42DF-892D-5DE31E8FB4B5Q34260546-23704D57-9350-4648-A23C-E42D4B8DEFF6Q34264624-C4D4DCAD-69FF-4531-B47D-B5FB9B6DD173Q34765755-E1AA6584-8D24-44E0-B7F6-A660BFB457E6Q34813843-765D0BF9-1C72-44EE-94AE-9BFF220BB203Q35116303-9FE648A1-7D09-43D7-991C-9DC5FBE319E3Q35123513-798DAC30-8FBE-43A7-8F01-C485C33B06ACQ35561483-57BAD477-FFAA-4301-89E6-1F42A6A87855Q35902870-CD943C8C-8394-4005-B91E-32BCFA1A3155Q36014076-075B9DAD-E56A-4465-A1FD-83306C8E36C4Q36419249-6A9F6BC6-9BD3-44F5-B195-7D8BAC89FDCBQ36557625-62762BDD-45C8-45A7-975E-9FFFFD7F9A1DQ36820961-F3657949-1D13-4B97-B7EB-0D60B08DEE2EQ36993980-089FAEBF-A5C1-4FC3-9D0F-334D04E25494Q37075420-1747008A-EE08-4031-B866-41393800EA78Q37351231-2F48B9B4-E876-41E9-BDE1-2DFB933D98C2Q37532382-7C358618-F35F-4A4D-B38A-F36541B61D47Q38016902-16B4BE8D-184F-4957-9CA9-A65E0F4B29D4Q38102788-90F1A695-F07B-4578-9C04-70316A58CB10Q38904874-F641A579-92B5-4CDF-9D3C-CBCB66C462BAQ38927961-3A9791FA-B511-4040-B9D8-E7C19A453D1EQ39272871-ED8EBD20-5BE0-4F65-B7BF-4FDCD6E11F60Q39307105-55F55ADF-0ECD-41A5-AFEA-94CC4E266F4DQ39471328-3C83FFFF-51FA-4601-906C-547C263476FEQ39510373-3979F421-FE22-400F-ADCE-64226518CFD3Q39593898-A4EE04C3-E2C2-4520-B59B-8E866AAC7500Q39596760-B588C609-994C-4CEC-8D06-9DF5E792CDE9Q39601763-6ECBD908-7B84-4DA7-A095-300988A07187Q40088521-61DE006C-B0A0-45D4-8FC4-3DEC5FA4D9F9Q42177134-A741CA6A-03CD-4E53-B1FA-B991263E56D6Q42936555-6327247D-848B-461C-86AC-50AE3189DB6BQ43852668-625D1BAD-4CF3-4634-86BB-642330996A61
P2860
New definition for the partial remission period in children and adolescents with type 1 diabetes
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
New definition for the partial ...... olescents with type 1 diabetes
@en
New definition for the partial ...... lescents with type 1 diabetes.
@nl
type
label
New definition for the partial ...... olescents with type 1 diabetes
@en
New definition for the partial ...... lescents with type 1 diabetes.
@nl
prefLabel
New definition for the partial ...... olescents with type 1 diabetes
@en
New definition for the partial ...... lescents with type 1 diabetes.
@nl
P2093
P2860
P356
P1433
P1476
New definition for the partial ...... olescents with type 1 diabetes
@en
P2093
Carine de Beaufort
Eugen J Schoenle
Francesco Chiarelli
Hilary Hoey
Hilde Bjoerndalen
Hvidoere Study Group on Childhood Diabetes
Lars Hansen
Peter Swift
Philip Hougaard
P2860
P304
P356
10.2337/DC08-1987
P407
P577
2009-05-12T00:00:00Z